Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

NCT00001104

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Behavior, +25 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • Stanford Univ School of Medicine Stanford, California, United States
  • Northwestern Univ Med School Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

NCT02172950

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Study Site 8400213 San Diego, California, United States
  • Study Site 8400241 Aurora, Colorado, United States
  • Study Site 8400118 Hartford, Connecticut, United States
  • Study Site 8400116 Miami, Florida, United States
View all 64 locations
View Trial Details
Completed

Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia

NCT03185897

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • University of Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
  • Michigan State University East Lansing, Michigan, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View all 23 locations
View Trial Details
Completed

Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ

NCT02962765

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Tulane University New Orleans, Louisiana, United States
  • Hemophilia Treatment Center of Nevada Las Vegas, Nevada, United States
View all 39 locations
View Trial Details
Completed

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

NCT04072237

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Medical Center "Hippocrates - N" Plovdiv, Bulgaria
  • Specialized Hospital for Active Treatment of Hematological Diseases Sofia, Bulgaria
  • Kirov Research Institute of Hematology and Blood Transfusion Kirov, Russia
  • National Medical Hematology Research Center Moscow, Russia
View Trial Details

Related conditions